ReviewInfection and drug resistance2016
Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature.
Review in Infection and drug resistance, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Relationships in anesthesia work areas between contamination measured as colony-forming units,Anesthesiology and perioperative science · 2026Article
- Methicillin-resistantCurrent pharmaceutical biotechnology · 2025Review
- Targeting bacterial growth in biofilm conditions: rational design of novel inhibitors to mitigate clinical and food contamination using QSAR.Journal of enzyme inhibition and medicinal chemistry · 2024Article
- Colonisation with multidrug-resistant organisms among dialysis patients at Universitas Academic Hospital.Southern African journal of infectious diseases · 2024Article
- Molecular characterization of typing and subtyping of Staphylococcal cassette chromosome SCCIranian journal of microbiology · 2023Article
- The nose is not enough: Multi-site sampling is best for MRSP detection in dogs and households.Veterinary dermatology · 2022Article
- Colonization of Extended-spectrum β-lactamase producing Enterobacterales and meticillin-resistantInfection prevention in practice · 2022Article
- Carbapenem-resistantFrontiers in microbiology · 2022Review
- Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin.Molecules (Basel, Switzerland) · 2021Article
- Predictive Role of Targeted, Active Surveillance Cultures for Detection of Methicillin-ResistantInfection and drug resistance · 2021Article
- Early Detection and Control of Methicillin resistant Staphylococcus aureus Outbreak in an Intensive Care Unit.Balkan medical journal · 2021Article
- Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016).Antimicrobial resistance and infection control · 2020Article
- Antibacterial Activity and Pharmacokinetic Profile of a Promising Antibacterial Agent: 22-(2-Amino-phenylsulfanyl)-22-Deoxypleuromutilin.Molecules (Basel, Switzerland) · 2020Article
- Characterization of SCCmec, spa types and Multi Drug Resistant of methicillin-resistant Staphylococcus aureus isolates among inpatients and outpatients in a referral hospital in Shiraz, Iran.BMC research notes · 2019Article
- Comparative assessment of methicillin resistant Staphylococcus aureus diagnostic assays for use in resource-limited settings.BMC microbiology · 2019Article
- Preoperative screening for nasal carriage of methicillin-resistantJournal of rural medicine : JRM · 2019Article
- In Vitro Activity Of Ceftaroline And Comparators AgainstInfection and drug resistance · 2019Article
- Transmission of methicillin-resistantJournal of general and family medicine · 2019Article
- Methicillin-resistant Staphylococcus aureus colonisation: epidemiological and molecular characteristics in an acute-care tertiary hospital in Singapore.Epidemiology and infection · 2018Article
- Genetic and phenotypic study of methicillin-resistantIranian journal of microbiology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe objective of this study was to evaluate the optimal number of sampling sites for detection of methicillin-resistant Staphylococcus aureus (MRSA) colonization.
methodsWe performed a Medline search from January 1966 to February 2014 for articles that reported the prevalence of MRSA at different body sites. Studies were characterized by study design, country and period of the study, number of patients and/or isolates of MRSA, specimen type, sites of MRSA isolation, study population sampled, diagnostic testing method, and percentage of the MRSA isolates at each site in relation to the total number of sites.
resultsWe reviewed 3,211 abstracts and 177 manuscripts, of which 17 met the criteria for analysis (n=52,642 patients). MRSA colonization prevalence varied from 8% to 99% at different body sites. The nasal cavity as a single site had MRSA detection sensitivity of 68% (34%-91%). The throat and nares gave the highest detection rates as single sites. A combination of two swabs improved MRSA detection rates with the best combination being groin/throat (89.6%; 62.5%-100%). A combination of three swab sites improved MRSA detection rate to 94.2% (81%-100%) with the best combination being groin/nose/throat. Certain combinations were associated with low detection rates. MRSA detection rates also varied with different culture methods.
conclusionA combination of three swabs from different body sites resulted in the highest detection rate for MRSA colonization. The use of three swab sites would likely improve the recognition and treatment of MRSA colonization, which may in turn reduce infection and transmission of MRSA to other patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.